The Impact of Medical Nutritional Therapy on the Efficacy of Premix Insulin in Glycemic Control in Patients with Type 2 Diabetes.

Senada Husaric, Azra Avdic Salihovic, Nedzad Kadric, Samra Iljazovic-Topic, Jasmina Pasic, Anida Divanovic
{"title":"The Impact of Medical Nutritional Therapy on the Efficacy of Premix Insulin in Glycemic Control in Patients with Type 2 Diabetes.","authors":"Senada Husaric,&nbsp;Azra Avdic Salihovic,&nbsp;Nedzad Kadric,&nbsp;Samra Iljazovic-Topic,&nbsp;Jasmina Pasic,&nbsp;Anida Divanovic","doi":"10.5455/msm.2023.35.13-17","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Medical nutritional therapy (MNT) is a key component in the treatment of Diabetes mellitus (DM). MNT is completely individual and should be present in the treatment of diabetes from the very beginning, continuously with pharmacological therapy, taking into account lifestyle, dietary habits and the type of antidiabetic therapy. Mistakes that are made when planning the diet are the absence of individual adjustment of the diet, which means that the number and time of meals, as well as the amount of UH per meal, is not adjusted to the patients' oral or insulin therapy according to their pharmacokinetics and pharmacodynamics.</p><p><strong>Objective: </strong>This study investigated the effect of MNT with reduced carbohydrate content (MNT M-ADA) on the efficacy of human and analogue premix insulin in patients with T2DM.</p><p><strong>Methods: </strong>Subjects were randomized into two groups (human and analog premix insulins), and then each group into two subgroups of 30 subjects each. One subgroup each on therapy with human and analog biphasic insulins was educated about MNT and learned to count UH, and then they applied MNT M-ADA for 24 weeks, unlike the other two subgroups. In this review, we present only the subgroup analysis on human and analog premix insulins that applied MNT M-ADA (200 g UH/day). Efficacy outcomes in the analysis of these subgroups were estimated changes in each subgroup from baseline to end point (week 24) and differences between subgroups at the end of the study in levels of glycated hemoglobin (HbA1c), self-measured glucose values (SMBG) and frequency of hypoglycemia.</p><p><strong>Results: </strong>Both subgroups of subjects with MNT M-ADA improved glycemic control, which was assessed by improvements in HBA1C, SMBG levels, without an increase in the frequency of hypoglycemia, but at the end of the study there was no statistically significant difference in the mentioned parameters between the subgroups.</p><p><strong>Conclusion: </strong>The effectiveness of MNT M-ADA in people with T2DM did not depend on the type of insulin, both insulin regimens are effective if the amount of ingested UH is taken into account.</p>","PeriodicalId":18358,"journal":{"name":"Materia Socio-Medica","volume":"35 1","pages":"13-17"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/68/MSM-35-13.PMC10122531.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Materia Socio-Medica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/msm.2023.35.13-17","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Medical nutritional therapy (MNT) is a key component in the treatment of Diabetes mellitus (DM). MNT is completely individual and should be present in the treatment of diabetes from the very beginning, continuously with pharmacological therapy, taking into account lifestyle, dietary habits and the type of antidiabetic therapy. Mistakes that are made when planning the diet are the absence of individual adjustment of the diet, which means that the number and time of meals, as well as the amount of UH per meal, is not adjusted to the patients' oral or insulin therapy according to their pharmacokinetics and pharmacodynamics.

Objective: This study investigated the effect of MNT with reduced carbohydrate content (MNT M-ADA) on the efficacy of human and analogue premix insulin in patients with T2DM.

Methods: Subjects were randomized into two groups (human and analog premix insulins), and then each group into two subgroups of 30 subjects each. One subgroup each on therapy with human and analog biphasic insulins was educated about MNT and learned to count UH, and then they applied MNT M-ADA for 24 weeks, unlike the other two subgroups. In this review, we present only the subgroup analysis on human and analog premix insulins that applied MNT M-ADA (200 g UH/day). Efficacy outcomes in the analysis of these subgroups were estimated changes in each subgroup from baseline to end point (week 24) and differences between subgroups at the end of the study in levels of glycated hemoglobin (HbA1c), self-measured glucose values (SMBG) and frequency of hypoglycemia.

Results: Both subgroups of subjects with MNT M-ADA improved glycemic control, which was assessed by improvements in HBA1C, SMBG levels, without an increase in the frequency of hypoglycemia, but at the end of the study there was no statistically significant difference in the mentioned parameters between the subgroups.

Conclusion: The effectiveness of MNT M-ADA in people with T2DM did not depend on the type of insulin, both insulin regimens are effective if the amount of ingested UH is taken into account.

Abstract Image

Abstract Image

Abstract Image

药物营养治疗对预混胰岛素控制2型糖尿病患者血糖效果的影响
背景:医学营养治疗(MNT)是糖尿病(DM)治疗的关键组成部分。MNT完全是个体化的,应该从一开始就出现在糖尿病的治疗中,持续使用药物治疗,同时考虑到生活方式、饮食习惯和抗糖尿病治疗的类型。在计划饮食时所犯的错误是缺乏对饮食的个人调整,这意味着进餐的次数和时间,以及每餐UH的量,没有根据患者的药代动力学和药效学来调整患者的口服或胰岛素治疗。目的:探讨低碳水化合物MNT (MNT M-ADA)对T2DM患者人胰岛素和类似物预混胰岛素疗效的影响。方法:将受试者随机分为人胰岛素和模拟胰岛素预混剂两组,每组分为2个亚组,每组30例。与其他两个亚组不同,分别接受人胰岛素和模拟双相胰岛素治疗的一个亚组接受了MNT和UH计数的教育,然后他们应用MNT M-ADA治疗24周。在这篇综述中,我们只介绍了应用MNT M-ADA (200 g UH/天)的人和模拟预混胰岛素的亚组分析。这些亚组分析的疗效结果是估计每个亚组从基线到终点(第24周)的变化,以及研究结束时亚组间糖化血红蛋白(HbA1c)水平、自测血糖值(SMBG)和低血糖发生频率的差异。结果:MNT - M-ADA患者的两个亚组均改善了血糖控制,通过HBA1C、SMBG水平的改善来评估,低血糖发生率未增加,但在研究结束时,亚组间上述参数无统计学差异。结论:MNT - M-ADA对T2DM患者的疗效与胰岛素类型无关,如果考虑到UH的摄入量,两种胰岛素方案都是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信